Epidemiology


Etiology


Pathophysiology

  • Most commonly due to a defect of the liver enzyme phenylalanine hydroxylase (PAH) → impaired conversion of phenylalanine to tyrosine → tyrosine becomes nutritionally essential (classical PKU)
  • Less commonly
    • Tetrahydrobiopterin deficiency (malignant PKU): due to tetrahydrobiopterin deficiency (a cofactor of phenylalanine metabolism), caused by a deficiency in dihydropteridine reductase (normally reduces dihydrobiopterin to BH4), resulting in:
      • Hyperphenylalaninemia due to ↓ conversion of phenylalanine to tyrosine → ↓ synthesis of catecholamines (BH4 is a cofactor for phenylalanine hydroxylase and tyrosine hydroxylase)
      • ↓ Synthesis of serotonin (BH4 is a cofactor for tryptophan hydroxylase) → deficiencies of neurotransmitters
      • Symptom severity varies between affected individuals.

Clinical features

  • Normal at birth due to maternal clearance of Phe in utero.
  • Symptoms manifest by 3–6 months of age if untreated.
  • Musty or mousy body/urine odor (due to phenylacetic acid accumulation).
  • Hypopigmentation (fair skin, blue eyes, blonde/fair hair) due to melanin synthesis inhibition by high Phe levels.
  • Eczematous rash (severe atopic-like dermatitis). c
  • Neurological features:
    • Progressive, irreversible intellectual disability (ID) and developmental delay.
    • Microcephaly. c
    • Seizures, spasticity, and hyperreflexia.
    • Psychiatric/behavioral disturbances (e.g., hyperactivity, anxiety).

Phenylketonuria

Mnemonic

Musty -> having a stale, moldy, or damp smell -> MOLD-E

Link to original


Diagnostics

  • Newborn Screening (Blood phenylalanine): Universal screening via heel prick 24-72 hours after birth. Measures Phe levels using tandem mass spectrometry. This is the primary screening test.
  • Serum Amino Acid Analysis: The confirmatory test. Shows ↑ Phenylalanine and ↓ Tyrosine levels in the plasma, confirming the diagnosis and establishing the severity.
  • Urinary Pteridine Analysis: Performed after a confirmed high Phe level to differentiate between PAH deficiency (classic PKU) and BH4 deficiency. Abnormal pterin profile indicates a defect in BH4 synthesis or regeneration.
  • Urinary Ferric Chloride Test: A historical, now obsolete, test. Urine turns a blue-green color in the presence of phenylpyruvic acid. Not used for screening or diagnosis today.

Treatment

  • Low phenylalanine and high tyrosine diet
  • BH4 deficiency: supplementation of BH4 and possibly levodopa and 5-hydroxytryptophan